AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05234515 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Patients will complete baseline preoperative questionnaires which will be repeated at 30 days and 90 days. These will evaluate generic and wound specific quality of life as well as decision conflict/decision regret.
Study NCT04354623 — intervention group
Intervention type: OTHER
Intervention: A 6-minute walk test
Description: Each subject will perform a 6-minute walk test during which gait assessment will be obtained from the APDM system (Portland, OR). In addition there will be four video cameras (on the front, back and sides) that will measure raw video data for our gait analysis. The camera does not record any facial data (in fact, 'deepfake' software in the system deletes all facial details) and the patient's movements are converted to a 'stick figure' prior to being saved in the system.
Study NCT06154837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK3862995B
Description: GSK3862995B will be administered.
Study NCT06154837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered.
Study NCT05689385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eHealth-based cardiac rehabilitation
Description: The 12-wk case manager-led eHCR program includes:~1. Individualized exercise prescription according to the results of cardiopulmonary exercise test.~2. At least one session of in-person physical therapy to familiarize participants with the process of exercise training before the initiation of telerehabilitation.~3. Telerehabilitation: a 30-minute moderate aerobic exercise training with remote monitoring and instruction using video conferencing. (Frequency: twice per week in the first 4 weeks, once per week in the 5th-8th week, once every 2 weeks in the 9th-12th week)~4. Additional self-exercise to achieve the target volume of 150-minute moderate aerobic exercise and 2 sessions of resistance training per week.~5. Patient education for secondary prevention delivered regularly via a communication app on the smartphone.~6. Weekly follow-up call from a case manager via phone call or communication app.
Study NCT06300554 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program App
Description: freely available well-being app
Study NCT04630405 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wright jet nebulizer
Description: Roxon Medi-Tech, Montreal, QC, Canada
Study NCT04630405 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Aerogen Solo
Description: Aerogen Ltd., Galway, Ireland
Study NCT05353816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Corheart 6 Left Ventricular Assist System
Description: Implantation of the Corheart 6 Left Ventricular Assist Device for mechanical circulatory support.
Study NCT05451849 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TC-510
Description: TC-510
Study NCT05451849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine
Study NCT05451849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide
Study NCT06422299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online, couples-based intervention
Description: During Phase 1 of the present study, the intervention will be iteratively developed using a rigorous, user-centered design approach through integration of knowledge gained from Phase 1 dyadic analyses and qualitative interviews, and existing gold-standard treatments for substance use among couples, including Integrative Behavioral Couples Therapy (IBCT; Christensen \& Doss, 2016) and Behavioral Couples Therapy for Alcohol (ABCT; McCrady et al, 1995) and substance use brief interventions for young adults (Halladay, et al., 2019; Tanner-Smith et al., 2015).
Study NCT04950673 — intervention group
Intervention type: DEVICE
Intervention: Cognivue
Description: Computerized Cognitive Assessment Device
Study NCT04836637 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Three capsules are to be consumed with one sachet dissolved in 200 ml. of water for breakfast and later for dinner resulting in a total of six capsules and two sachets via oral consumption daily.
Study NCT04836637 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Calcium-carbonate
Description: Three capsules are to be consumed with one sachet dissolved in 200 ml. of water for breakfast and later for dinner resulting in a total of six capsules and two sachets via oral consumption daily.
Study NCT04836637 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium-enriched permeate
Description: Three capsules are to be consumed with one sachet dissolved in 200 ml. of water for breakfast and later for dinner resulting in a total of six capsules and two sachets via oral consumption daily.
Study NCT04836637 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium-enriched permeate with Inulin
Description: Three capsules are to be consumed with one sachet dissolved in 200 ml. of water for breakfast and later for dinner resulting in a total of six capsules and two sachets via oral consumption daily.
Study NCT05270629 — intervention group
Intervention type: OTHER
Intervention: Antegrade and retrograde anastomoses
Description: Patients who had received both antegrade and retrograde anastomoses.
Study NCT05270629 — intervention group
Intervention type: OTHER
Intervention: Antegrade-only anastomoses
Description: Patients who had received antegrade-only anastomoses.
Study NCT05581277 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Description: This intervention focuses on a wide range of emotional psychopathology, allowing care for comorbid disorders and subclinical or unspecified symptoms, which reduces treatment times and costs, and improves response to treatment. The intervention will be carried out in an online-individual format.
Study NCT06374433 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Occipital tACS at IAF-2Hz
Description: tACS applied to occipital areas at 2 Hz below the individual alpha frequency (IAF)
Study NCT06374433 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Occipital tACS at IAF+2Hz
Description: tACS applied to occipital areas at 2 Hz above the individual alpha frequency (IAF)
Study NCT06374433 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Frontal tACS at 4-7 Hz
Description: tACS applied to frontal areas at 4-7 Hz
Study NCT06374433 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Occipital tRNS
Description: tRNS applied to occipital brain regions
Study NCT06374433 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Frontal tRNS
Description: tRNS applied to frontal brain regions
Study NCT06374433 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham/placebo tACS
Description: tACS is activated only for 30 seconds and then turned off, thus resulting ineffective
Study NCT06374433 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham/placebo tRNS
Description: tRNS is activated only for 30 seconds and then turned off, thus resulting ineffective
Study NCT05929222 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy
Description: Involved-Site Radiation Therapy 24Gy
Study NCT05929222 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus Obinutuzumab
Description: Involved-Site Radiation Therapy 24Gy followed by Obinutuzumab 1000mg flat dose 4 doses weekly plus addition 4 doses every 3 weeks
Study NCT06242184 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Group A(Nano-fortified Adhesive)
Description: Nano-fortified dentin adhesive
Study NCT06242184 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Group B(Adhesive without nanoparticles)
Description: Conventional adhesives without nanoparticles
Study NCT05195034 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: The 200ug dexmedetomidine will be diluted into a 50ml syringe and administered with continuous infusion at a rate of 0.2 µg/kg/hour until the end of dural closure.
Study NCT05195034 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% saline
Description: The 0.9% saline is administered with the same volume at the same speed as the other group.
Study NCT05683600 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
Description: Intramuscular injection of Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001 in the deltoid muscle of the upper arm at day 0. The inoculation dose is 0.5 mL.
Study NCT05683600 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Intramuscular injection of placebo in the deltoid muscle of the upper arm at day 0. The inoculation dose is 0.5 mL.
Study NCT04766879 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transfluthrin
Description: Passive emanator with formulated transfluthrin
Study NCT04766879 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Passive emanator with formulated inert ingredients
Study NCT06573411 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACEI/ARB+ finerenone
Description: The intervention group will be administered maximum tolerable dose of ACEI/ARB and finerenone 20 mg QD.
Study NCT06573411 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ACEI/ARB+ Placebo
Description: Control patients will be administered maximum tolerable dose of ACEI/ARB and a placebo.
Study NCT06408285 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQC3927 powder for inhalation
Description: TQC3927 is a targeted inhibitor.
Study NCT06408285 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TQC3927 powder for inhalation placebo
Description: TQC3927 powder for inhalation placebo contains no active substance.
Study NCT06417749 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control arm
Description: Participants will receive a copy of the Chinese Dietary Guidelines leaflet at baseline.
Study NCT06417749 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intervention arm
Description: Participants will be given three MIND diet education videos on different topics at baseline and during follow-up. In addition, each participant will receive a MIND diet education brochure at baseline and some food supply during follow-up.
Study NCT04936009 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: Subjects will receive both active and sham TMS in a randomized crossover assignment involving two study sessions
Study NCT04936009 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: Subjects will receive both active and sham TMS in a randomized crossover assignment involving two study sessions
Study NCT06517706 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Combination of tDCS (device) with cognitive training (behavioral)
Description: Participation in 15 one-hour sessions distributed over three weeks. During each session participants will receive two sessions of tDCS plus cognitive training with the Categorization Program
Study NCT06517706 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Categorization Program
Description: Participation in 15 one-hour sessions distributed over three weeks. During each session participants will receive cognitive training and sham tDCS
Study NCT05988385 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Positive airway pressure
Description: Positive airway pressure (PAP) therapy is a sleep apnea treatment that uses a stream of compressed air to support the airway during sleep. With PAP therapy, a mask is worn during sleep and a portable machine gently blows pressurized room air from into your upper airway through a tube connected to the mask. This positive airflow helps keep the airway open, preventing the collapse that occurs during apnea, thus allowing normal breathing.
Study NCT05988385 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Positive airway pressure
Description: Positive airway pressure (PAP) therapy is a sleep apnea treatment that uses a stream of compressed air to support the airway during sleep. With PAP therapy, a mask is worn during sleep and a portable machine gently blows pressurized room air from into your upper airway through a tube connected to the mask. This positive airflow helps keep the airway open, preventing the collapse that occurs during apnea, thus allowing normal breathing.
Study NCT05988385 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oral appliance therapy
Description: Oral appliance therapy involves the use of a dental appliance or oral mandibular advancement device that prevents the tongue from blocking the throat and/or advances the lower jaw forward. These devices help keep the airway open during sleep.
Study NCT05988385 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Oral appliance therapy
Description: Oral appliance therapy involves the use of a dental appliance or oral mandibular advancement device that prevents the tongue from blocking the throat and/or advances the lower jaw forward. These devices help keep the airway open during sleep.
Study NCT05988385 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Positional therapy
Description: A NightShift Sleep Positioner (Advanced Brain Monitoring) is a neck vibration device, FDA approved to treat positional sleep apnea. The device detects patient supine position and delivers a small vibratory signal to the back of the neck to prompt position change.
Study NCT05988385 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Positional therapy
Description: A NightShift Sleep Positioner (Advanced Brain Monitoring) is a neck vibration device, FDA approved to treat positional sleep apnea. The device detects patient supine position and delivers a small vibratory signal to the back of the neck to prompt position change.
Study NCT04711304 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Umbilical Cord-derived Wharton's Jelly
Description: Intraarticular injection
Study NCT05942183 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ONSD
Description: ultrasound measurement of the optic nerve sheath diameter
Study NCT04711304 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronic acid
Description: Intraarticular injection
Study NCT04711304 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Intraarticular injection
Study NCT05935618 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT-ING program ( Activity-based skill- and strength training to improve ingestion)
Description: The intervention is based on a client-centered Occupational therapy task-oriented approach, in which real objects are employed in a realistic context. The intervention uses the effortful swallowing in combination with advancing steps of liquid and food items as resistive forces to challenge the swallow in a safe environment during eating and drinking activities. Progression is realized based on pre-determined progression rules to ensure the right challenges in combination with safety (Hansen et al, 2023).
Study NCT06334601 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tests of upper airway collapsibility and muscle responsiveness.
Description: Upper airway collapsibility, upper airway muscle responsiveness and loop gain will be assessed during single study visit.~Polysomnography
Study NCT06327204 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 940-nm diode laser / one session
Description: laser therapy using a 940-nm diode laser / one session per week
Study NCT06327204 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 940-nm diode laser / two session
Description: laser therapy using a 940-nm diode laser / two session per week
Study NCT06327204 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 940-nm diode laser/ three session
Description: laser therapy using a 940-nm diode laser / three session per week
Study NCT06023758 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN026
Description: KN026：30 mg/kg Q3W
Study NCT06023758 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN046
Description: KN046：5 mg/kg Q3W
Study NCT06023758 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX
Description: Oxaliplatin 130mg/m2 d1，Capecitabine 1000mg/m2 d1-14，Q3W
Study NCT05039931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GNC-035
Description: Administration by intravenous infusion.
Study NCT05863754 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Networked Neuroprosthesis Device
Description: The Networked Neuroprosthesis Device is an implantable, configurable neuromodulation platform that provides functional movement by the coordinated activation of peripheral neural pathways activating innervated paralyzed muscles, and sensing of physiological signals.
Study NCT05055674 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motherly app
Description: The Motherly app is organized in four different modules: 1) Library: a collection of brief texts on several topics related to health and pregnancy, 2) Health: journeys with varying degrees of interactivity designed to teach and engage participants in well-established psychological techniques (behavioral activation, cognitive restructuring, emotion regulation, stress management techniques, mindfulness and meditation, sleep hygiene techniques), 3) Pregnancy and motherhood: a module to help mothers keep track of their health care visits, medical exams, and their childrens' development, and 4) Profile: a module allowing participants to keep track of activities and goals completed in the Health module journeys, and to assess depression and anxiety symptoms with brief questionnaires, with results displayed graphically in a timeline and in the the form of short feedback texts.
Study NCT05055674 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: COMVC app
Description: The COMVC displays over 30 brief psychoeducational videos on several topics related to general mental health, such as depression, anxiety, stress, sleep, problem solving techniques, among others. Psychoeducation is limited to video only (no interactivity). The content of these videos was developed by clinicians, researchers, and professors from the Psychiatry Department of the Medical School of the University of Sao Paulo and from the Federal University of Rio Grande do Sul. Mental health monitoring is delivered by means of brief questionnaires assessing depression and anxiety symptoms, which can be filled at users' discretion. Users' responses are displayed graphically in a timeline and they receive short feedback texts based on assessment results.
Study NCT05192577 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: At the beginning of the session, an electrode will be attached to the participant's ankle. Electrical stimulation will be applied to estimate the electrical perception threshold. This threshold will be used as condition stimuli when different thermal thresholds are assessed.
Study NCT04926675 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological Therapy
Description: Participants will be receiving their one-to-one psychological therapy from IAPT as usual. They typically receive between 6 and 12 sessions with a psychological practitioner.
Study NCT04926675 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Debt Advice
Description: Participants will receive one-to-one support from a Citizen's Advice (CA) money advisor for as long as needed to resolve any money worries currently affecting their mental health.
Study NCT05954234 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Postural re-education
Description: Each session of the experimental approach will be composed of 40 minutes of postural exercise. Participants will be asked to maintain two different postures to stretch both the anterior and posterior muscle chains. The first posture will consist of lying on the back maintaining the extension of the legs to release the respiratory diaphragm and stretch the anterior muscle chain. For the second posture, participants wiil be asked to lie on their back with their legs flexed to stretch the posterior chai. For each posture, the physical therapist will use verbal commands and manual contact to maintain alignment and make the necessary postural corrections to optimize the stretching and discourage compensatory movements.~10 sessions of the allocated intervention will be performed and organized in 2 times a week for 5 weeks.
Study NCT05954234 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spinal mobilization
Description: This approach will consist of 40 minutes of thoracolumbar spine mobilization. Two different mobilizations will be carried out. In the first one the patient will be in sitting position with both legs out of the bed and a mobilization in antero-posterior direction will be provide by the physiotherapist; the second one will consist in rotational mobilisation provide with the patient in lateral decubitus position.~10 sessions of the allocated intervention will be performed and organized in 2 times a week for 5 weeks.
Study NCT05954234 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Perineal Exercises
Description: Perineal Exercises will be performed in both the allocated approach. The protocol will consist in 10 minutes of perineal contraction and relaxation and 10 minutes of stretch-reflex for a total of 20 minutes of perineal exercises.10 sessions of the allocated intervention will be performed and organized in 2 times a week for 5 weeks.